stars 1 stars 2 stars 3

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow. Biosyntia is located at a startup incubator (Symbion) in Copenhagen, just a few kilometers from the center of the city.

Biosyntia Questions

The Biosyntia annual revenue was $7 million in 2026.

Martin Plambech is the CEO of Biosyntia.

11 people are employed at Biosyntia.

Biosyntia is based in Copenhagen, South Denmark.

The NAICS codes for Biosyntia are [54, 541, 541713, 5417, 54171].

The SIC codes for Biosyntia are [873, 87].

Top Biosyntia Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users